Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine vs Persica mouthwash for prevention of ventilator-associated pneumonia
IRCT20231122060135N1Phase 3Completed
- Sponsor
- Zabol University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in ventilator-associated pneumonia (VAP) comparing Chlorhexidine mouthwash with Persica mouthwash (2 arms). Primary endpoint: Incidence of ventilator-associated pneumonia. Started Jan 2024; status: completed.
02
Drugs
chlorhexidinePersica mouthwash
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20231122060135N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231122060135N1.